| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/21/2008 | US20080200411 Modulating ATP gated ion channel P2X7R protein; administering agonistic agent; depression, anxiety, bipolar disorder |
| 08/21/2008 | US20080200391 Stimulating differentiation in growth of osteoblasts and osteoclasts; wound healing of bone fractures and de novo bone formation; osteoporosis; bone cancer treatment; polynucleotide encoding polypeptide; genetic engineering |
| 08/21/2008 | US20080200379 Diagnostic markers of human female infertility |
| 08/21/2008 | US20080200369 Inhibiting bystin mediated arrest and promoting autophosphorylation of epidermal growth factor receptor; sperm motility, embryonic stem cell formation, trophoblast formation, neuronal growth |
| 08/21/2008 | US20080199972 conjugate of the analyte and an europium (or terbium) cryptate fluorophore together with a defined quantity of antibodies which are specific for the analyte, and second antibody which is specific for the fluorophore; fluorescence quenching |
| 08/21/2008 | US20080199952 Genetic vaccine comprising an expression vector encoding a Streptococcus pneumoniae pneumolysin polypeptide that lacks hemolytic activity |
| 08/21/2008 | US20080199934 Adding functional groups to peptides for use in preparation of muscle and silk protein |
| 08/21/2008 | US20080199912 Methods for Obtaining Optically Active Epoxides and Diols from 2,3-Disubstituted and 2,3-Trisubstituted Epoxides |
| 08/21/2008 | US20080199907 Method For Preparing a Target Protein Using the Shsps |
| 08/21/2008 | US20080199892 Using glycosylation profile thyrotropin as diagnostic indicator of thyroid disorders |
| 08/21/2008 | US20080199888 Follicle stimulating hormone receptor for use in identifying modulators for prevention and treatment of osteoporosis, menopausal, prostate cancer and polycystic ovary syndrome (PCOS) |
| 08/21/2008 | US20080199887 Compounds and methods for use in detecting gabapentin |
| 08/21/2008 | US20080199883 Protein kinase (PAPAP) for use in diagnosis, prevention and treatment of nervous system disorders |
| 08/21/2008 | US20080199881 MN Gene and Protein |
| 08/21/2008 | US20080199879 Method of Assaying Alzheimer's Disease and Diagnostic Reagent |
| 08/21/2008 | US20080199876 MutS homolog 5 (MSH5) variant for use as diagnostic/ prognostic indicator of cell proliferative disorders |
| 08/21/2008 | US20080199869 Novel mycobacterium tuberculosis protein composition |
| 08/21/2008 | US20080199860 Variants of the alpha 1 subunit of human ampk |
| 08/21/2008 | US20080199532 Congestive heart failure; induce vasodilation |
| 08/21/2008 | US20080199496 Protein disulfide isomerase for therapy, detection, prevention of leishmaniasis; parasiticides |
| 08/21/2008 | US20080199492 Env Polypeptide Complexes and Methods Of Use |
| 08/21/2008 | US20080199483 Long lasting fusion peptide inhibitors of viral infection |
| 08/21/2008 | US20080199482 Method For Inhibiting The Transendothelial Migration Of Cells Such As Leukocytes Or Tumor Cells By A Cd-Binding Substance And Uses Thereof |
| 08/21/2008 | US20080199481 B cell-attracting chemokine 1 specific immunoglobulin for use in treatment and prevention of rheumatoid arthritis |
| 08/21/2008 | US20080199479 Method of treating a muscle-related condition with modified IGF1 polypeptides |
| 08/21/2008 | US20080199476 Urokinase-type plasminogen activator receptor epitope, monoclonal antibodies derived therefrom and methods of use thereof |
| 08/21/2008 | US20080199475 Novel glycosylated peptide target in neoplastic cells |
| 08/21/2008 | US20080199473 Novel Gene and Protein Associated With Angiogenesis and Endothelial Cell-Specific Apoptosis |
| 08/21/2008 | US20080199471 Optimized cd40 antibodies and methods of using the same |
| 08/21/2008 | US20080199469 Using A20 binding inhibitor of NF- kappa B (ABIN) to stabilize MEK kinase and treat and/or prevent inflammatory diseases |
| 08/21/2008 | US20080199467 Immunoglobulin supergene fusion for use in treatment of vascular disorders |
| 08/21/2008 | US20080199466 Activation-inducible lymphocyte immunomediatory molecule specific immunoglobulin for treating and preventing inflammatory, autoimmune, ischemic, transplant and/or allergic disorders |
| 08/21/2008 | US20080199465 Accelerated lymphocyte homing agent such as fingolimod and one or more compounds selected from an antibody to the IL-2 receptor, an immunosuppressive macrocyclic lactone and a soluble human complement inhibitor |
| 08/21/2008 | US20080199463 Method for treating multiple myeloma |
| 08/21/2008 | US20080199457 Tetraspanin specific immunoglobulin for use in treatment and prevention of allergic disorders; immunotherapy |
| 08/21/2008 | US20080199456 Immunogens; vaccines; fusion proteins; antibodies; host cells; diagnostic kits |
| 08/21/2008 | US20080199455 Conformation specific antibodies that bind trefoil factors and methods of treating cancers and proliferation disorders using same |
| 08/21/2008 | US20080199437 Lrp4/Corin Dopaminergic Neuron Progenitor Cell Markers |
| 08/21/2008 | US20080199436 Binds to cerebrovascular endothelial cell; expression vectors; micelle, liposome or microcapsule used as carriers |
| 08/21/2008 | US20080199396 Radioisotope Labelled Biological Compositions, And Their Use In Accelerator Mass Spectrometry |
| 08/21/2008 | DE60037007T2 Angereicherte zentralnervensystem-zellpopulationen Enriched cns-cell populations |
| 08/21/2008 | CA2677782A1 Anti fgf23 antibody and a pharmaceutical composition comprising the same |
| 08/21/2008 | CA2677748A1 Binding members for ige molecules |
| 08/21/2008 | CA2677621A1 Novel antibodies |
| 08/21/2008 | CA2677597A1 Binding members for ige molecules |
| 08/21/2008 | CA2676766A1 Anti-robo4 antibodies and uses therefor |
| 08/21/2008 | CA2661853A1 Monoclonal antibody directed against the human ldl receptor |
| 08/20/2008 | EP1959018A1 Optimizing glycan processing in plants |
| 08/20/2008 | EP1959015A2 Secreted streptococcus pneumoniae proteins |
| 08/20/2008 | EP1959014A2 Antibodies against insulin-like growth factor I receptor and uses thereof |
| 08/20/2008 | EP1959013A1 Human circulating virus inhibitory peptide (VRIP) and its use |
| 08/20/2008 | EP1959009A1 Genetically recombinant anti-perp antibody |
| 08/20/2008 | EP1958966A2 Methods for modulating T cell responses by manipulating a common cytokine receptor gamma chain |
| 08/20/2008 | EP1958965A2 Agonist antibodies to a musk receptor, and their therapeutic uses |
| 08/20/2008 | EP1958962A2 Artificial antibody polypeptides |
| 08/20/2008 | EP1958959A2 Methods and proteins for the prophylactic and/or therapeutic treatment of the four serotypes of dengue virus and other flaviviruses |
| 08/20/2008 | EP1958958A1 Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
| 08/20/2008 | EP1957986A2 Intraocular pressure-regulated early genes and uses thereof |
| 08/20/2008 | EP1957639A1 Microginin producing proteins and nucleic acids encoding a microginin gene cluster as well as methods for creating microginins |
| 08/20/2008 | EP1957638A1 Uses of the fcrn receptor |
| 08/20/2008 | EP1957540A2 Binding polypeptides and uses thereof |
| 08/20/2008 | EP1957539A2 Human monoclonal antibodies to protein tyrosine kinase 7 (ptk7) and their use |
| 08/20/2008 | EP1957538A2 Uses of anti-cd40 antibodies |
| 08/20/2008 | EP1957537A2 Competitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 08/20/2008 | EP1957536A2 Noncompetitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 08/20/2008 | EP1957535A1 Human bnp immunospecific antibodies |
| 08/20/2008 | EP1957534A1 Therapeutic vaccines targeting hmgb1 |
| 08/20/2008 | EP1957533A2 METHODS FOR GENERATING MONOVALENT IgG |
| 08/20/2008 | EP1957532A1 Methods and reagents for elimination or reduction of false positives in the analysis of a sample |
| 08/20/2008 | EP1957531A2 Binding polypeptides with diversified and consensus vh/vl hypervariable sequences |
| 08/20/2008 | EP1957530A2 Human antibodies against il13 and therapeutic uses |
| 08/20/2008 | EP1957520A2 Polyvalent chimeric ospc vaccinogen and diagnostic antigen |
| 08/20/2008 | EP1957113A2 Polymer particles for delivery of macromolecules and methods of use |
| 08/20/2008 | EP1957108A1 Glioma-specific antibodies against behab/brevican for diagnostic and therapeutic applications |
| 08/20/2008 | EP1957106A2 Antagonist antibodies directed against calcitonin gene-related peptide and methods using same |
| 08/20/2008 | EP1556488B1 Hf-chondroosteomodulin, production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases |
| 08/20/2008 | EP1532165B1 Pesticidally active proteins and polynucleotides obtainable from paenibacillus species |
| 08/20/2008 | EP1409654B1 Immunological control of beta-amyloid levels in vivo |
| 08/20/2008 | EP1356052B1 Production of full antibodies in procaryotic cells |
| 08/20/2008 | EP1334123B1 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases |
| 08/20/2008 | EP1333850B1 Use of il-13 inhibitors for the treatment of tumors |
| 08/20/2008 | EP1244791B1 Method for producing 6-o-alpha-d-glucopyranosyl-d-sorbitol |
| 08/20/2008 | EP1232262B1 Recombinant gelatin in vaccines |
| 08/20/2008 | EP1228210B1 A method for detecting prostate cancer |
| 08/20/2008 | EP1075493B1 Dna encoding snorf25 receptor |
| 08/20/2008 | EP0826042B1 Genetic sequences and proteins related to alzheimer's disease, and uses therefor |
| 08/20/2008 | EP0724651B1 Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus |
| 08/20/2008 | EP0587780B2 Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits |
| 08/20/2008 | CN101248178A Gene capable of controlling differentiation/growth of plant, and use of the same |
| 08/20/2008 | CN101248090A Polyclonal antiserum against a universal tumor antigen |
| 08/20/2008 | CN101248089A Human monoclonal antibodies to programmed death ligand 1(PD-L1) |
| 08/20/2008 | CN101248088A Anti-il-23 antibodies |
| 08/20/2008 | CN101248087A Improved nanobodies(tm) against tumor necrosis factor-alpha |
| 08/20/2008 | CN101245338A Immunity colloidal gold test paper strip for testing sulfalene oxazole relict and manufacture method thereof |
| 08/20/2008 | CN101245108A Antihuman CD34 antibody, producing process and uses thereof |
| 08/20/2008 | CN101245107A Antihuman transferrin acceptor human source antibody and uses thereof |
| 08/20/2008 | CN101245106A Anti-VRGF acceptor monoclone antibody, preparation method and application thereof |
| 08/20/2008 | CN101245105A Anti-amyloid antibodies, compositions, methods and uses |
| 08/20/2008 | CN101245102A Process for producing natural pyrethrin polyclonal antibody |
| 08/20/2008 | CN101245101A Antihuman CD146 monoclone antibody, composition containing the same, and method for testing dissolubility CD146 |